Redhill Biopharma
RDHL
$0.42
Share price
9.16%
Change (1 day)
-85.88%
Change (1 year)
Categories
Operating Margin for Redhill Biopharma (RDHL)
Operating Margin as of April 2024 (TTM): -102.01%
According to Redhill Biopharma's latest financial reports and stock price the company's current Operating Margin is -102.01%. At the end of 2021 the company had an Operating Margin of -113.98%.
Operating Margin history for Redhill Biopharma from 2012 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -113.98% | -3.7% |
| 2020 | -118.36% | -82.4% |
| 2019 | -672.45% | 44.81% |
| 2018 | -464.35% | -59.15% |
| 2017 | -1,136.61% | -96.09% |
| 2016 | -29,079.21% | -95.86% |
| 2015 | -703,000.00% | 460253.09% |
| 2014 | -152.71% | -99.83% |
| 2013 | -88,566.67% | 37.23% |
| 2012 | -64,537.50% | -4.25% |
| 2011 | -67,404.35% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | 18.21% | -117.85% | 🇫🇷 France |
 Merck MRK | 27.73% | -127.18% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -122.10% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -20.53% | -79.87% | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | 13.86% | -113.59% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.